The ECRI Institute will be holding its 23rd Annual Conference on November 16 – 17, 2016 in Washington, DC at the National Academy of Sciences. The event will carry the theme “Health Systems and Addiction: The Use and Misuse of Legal Substances”.
Conference Main Theme
We’ve all read enough headlines about addiction and overdose. This conference is about what to do about it. Millions of prescriptions are written for drugs like opioids, stimulants, antidepressants. Many, but not all, are written for legitimate, evidence-based, medical purposes. Perspectives vary on how to address the human and financial costs of both use and misuse. The balance of the two is largely missing from the national discussion, and so is the changing role of health systems. The issues are complex and intertwined.
“Health Systems and Addiction: The Use and Misuse of Legal Substances” is a free, status-taking conference designed for a broad audience. It is appropriate for providers who specialize in addiction, but primarily targets health system executives, practitioners, researchers and policy makers who are seeking a greater understanding of substance use disorders and the role health systems play within acute-care and community-based care settings. Public and payment policies shape how these institution-based systems act and this will be carefully examined. National thought leaders will bring evidence and insights on the scientific understanding of addiction, innovations in the prevention of misuse of legal substances, and initiatives to treat and manage addiction.
The conference will begin by framing issues to better understand the interface between the use and misuse of legal substances, and which parts of health systems should be playing which roles in improving care and lessening harm. This will set the stage for understanding issues that are central to both policy and practice.
Highlights of main conference sessions:
- Scientific foundations of problems surrounding addictive substances, including the epidemiology and the brain science that helps distinguish the effect of one substance from another
- Impact of the legalization of marijuana in states like Colorado
- Roles and responsibilities of federal agencies, state governments, the Department of Defense, and the Department of Veterans Affairs
- Provider issues, such as which chronic and acute care treatment models are working to create effective immediate and longer term treatment and recovery, with an examination of access, coordination and transitions of care
- Role of public and private payers and the incentives that condition and drive healthcare systems towards various paths
- Discussion by major health system CEOs on the incentives and disincentives for population-based and institutional care
- Barriers and solutions to effective prevention of misuse and to successful treatment programs
And in our capstone session, we will have an extraordinary real-world example of how to create the political will needed to affect change.
- Conference Sponsors
- Agency for Healthcare Research and Quality (AHRQ)
- American Association for the Advancement of Science (AAAS)
- Department of Veterans Affairs
- ECRI Institute
- Jayne Koskinas Ted Giovanis Foundation for Health and Policy
- Kaiser Permanente
- Leonard Davis Institute of Health Economics
- Patient-Centered Outcomes Research Institute (PCORI)
- University of Pennsylvania Health System